Article Text

Download PDFPDF
The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies
  1. W A C Sewell,
  2. V M Brennan,
  3. M Donaghy,
  4. H M Chapel
  1. Department of Immunology, John Radcliffe Hospital, Oxford OX3 9DY, UK
  1. Dr H M Chapel.

Abstract

High dose intravenous immunoglobulin therapy is becoming the established maintenance treatment for several neurological conditions. Therapeutic immunoglobulin is expensive and its administration is time consuming. Efficacy is variable and must be closely monitored. Here, we show that self infused immunoglobulin at home, combined with daily functional strength diaries to predict dose and dosage intervals, is effective, time saving, and convenient for both patients and medical staff.

  • chronic demyelinating neuropathy
  • intravenous immunoglobulin
  • home therapy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes